Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Here’s Why Novavax Shares Are Moving

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher in sympathy with Moderna Inc (NASDAQ: MRNA), which reported better-than-expected second-quarter results.
byHenry Khederian
August 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Novavax, Inc. (NASDAQ:NVAX) shares are trading higher in sympathy with Moderna Inc (NASDAQ:MRNA), which reported better-than-expected second-quarter results.

Quarterly revenue for Moderna was $4.75 billion compared to $4.34 million a year ago, beating the consensus of $4.07 billion.

Moderna has authorized an additional share repurchase program for $3 billion. The $3 billion repurchase program announced in February is continuing and currently has approximately $1 billion outstanding… Read More

See Also: Why Kintara Therapeutics Stock Is Skyrocketing Today

According to data from Benzinga Pro, Novavax has a 52-week high of $277.80 and a 52-week low of $34.88.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Cleveland-Cliffs, Nucor Shares Are Sliding Tuesday: What’s Going On?

By Adam Eckert
April 23, 9:12 AM
After the market close on Monday, Cleveland-Cliffs reported first-quarter revenue of $5.2 billion, which missed the consensus estimate of $5.346 billion, according to Benzinga Pro. The company reported adjusted earnings of 18 cents per share, which missed analyst estimates of 22 cents per share. Steel shipments came in at 3.9 million net tons in the first quarter.

CLF